Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis

Revmatologiia

Volumn 40, Issue 12, 2001, Pages 1375-1383

  De Nijs, R N J ^a   Jacobs, J W G ^a   Bijlsma, J W J ^a   Lems, W F ^b   Laan, R F J M ^c   Houben, H H M ^d   Ter Borg, E J ^e   Huisman, A M ^f   Bruyn, G A W ^g   Van Oijen, P L M ^h   Westgeest, A A A ⁱ   Algra, A ^a   Hofman, D M ^j  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Sittard Geleen Heerlen   (Netherlands)

^e ST ANTONIUS HOSPITAL   (Netherlands)

^f SINT FRANCISCUS GASTHUIS   (Netherlands)

^g MEDICAL CENTER LEEUWARDEN   (Netherlands)

^h JEROEN BOSCH HOSPITAL   (Netherlands)

ⁱ Diaconessenhuis   (Netherlands)

^j Ziekenhuis Hilversum   (Netherlands)

more..

Author keywords

Corticosteroids; Prevalence; Rheumatoid arthritis; Symptomatic vertebral fractures; Vertebral deformities

Indexed keywords

ANALGESIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CHLORTALIDONE; CORTICOSTEROID; ESTROGEN; FLUORIDE; METHOTREXATE; PREDNISONE; THIAZIDE DIURETIC AGENT; VITAMIN D;

AGED; ARTICLE; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOSE RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK; SCORING SYSTEM; SYMPTOM; VERTEBRA FRACTURE; VERTEBRA MALFORMATION;

AGED; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PREDNISOLONE; PREVALENCE; RISK FACTORS; SPINAL FRACTURES; SPINE;

EID: 0035684828     PISSN: 13100505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990;112:352-64.
2. Adachi JD, Bensen WJ, Hodsman AB. Corticosteroid-induced osteoporosis. Semin Arthritis Rheum 1993; 22:375-84.
3. Klein RG, Arnaud SB, Gallagher JC, DeLuca HF, Riggs BL. Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose. J Clin Invest 1977;60:253-9.
4. Hahn TJ, Halstead LR, Bran DT. Effects of short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man. J Clin Endocrinol Metab 1981;52:111-5.
5. Suzuki Y, Ichikawa Y, Saito E, Homma M. Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism 1983;32:151-6.
6. Gronowicz G, McCarthy MB. Glucocorticoids inhibit the attachment of osteoblasts to bone extracellular matrix proteins and decrease β-1 integrin levels. Endocrinology 1995;136:598-608.
7. Dykman TR, Gluck OS, Murphy WA, Hahn TJ, Hahn BH. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 1985;28:361-8.
8. Reid IR, Heap SW. Determinants of vertebral mineral density in patients receiving longterm glucocorticoid therapy. Arch Intern Med 1990; 150:2545-8.
9. Verstraeten A, Dequeker J. Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids. Ann Rheum Dis 1986;45:852-7.
10. Michel BA, Bloch DA, Wolf F, Fries JF. Fractures in rheumatoid arthritis: an evaluation of associated risk factors. J Rheumatol 1993;20:1666-9.
11. Laan RF, van Riel PL, van Erning LJ, Lemmens JA, Ruijs SH, van de Putte LB. Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisone therapy. Br J Rheumatol 1992;31:91-6.
12. Eastgate JA, Wood NC, Di Giovine FS, Symons JA, Grinlinton FM, Duff GW. Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet 1988;ii:706-9.
13. Arend WP, Dayer J-M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990;33:305-15.
14. Spector TD, Hall GM, McCloskey EV, Kanis JA. Risk of vertebral fracture in women with rheumatoid arthritis. Br Med J 1993;306:58.
15. Gough AK, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet 1994;344:23-7.
16. Laan RF, Buijs WC, Verbeek AL et al. Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity. Ann Rheum Dis 1993;52:21-6.
17. Hooyman JR, Melton LJ, Nelson AM, O'Fallon WM, Riggs BL. Fractures after rheumatoid arthritis. Arthritis Rheum 1984;27:1353-61.
18. Kleerekoper M. Vertebral fracture or vertebral deformity. Calcif Tissue Int 1992;50:5-6.
19. Härmä M, Heliovaara M, Aromaa A, Knekt P. Thoracic spine compression fractures in Finland. Clin Orthop 1986;205:188-94.
20. Melton LJ III, Kan SH, Frye MA, Wahner HW, O'Fallon MO, Riggs BL. Epidemiology of vertebral fractures in women. Am J Epidem 1989;129: 1000-10.
21. O'Neill TW, Varlow J, Felsenbeng D et al. Variation in vertebral height ratios in population studies. European Vertebral Osteoporosis study. J Bone Miner Res 1994; 9:1895-907.
22. Lems WF, Jahangier ZN, Jacobs JWG, Bijlsma JWJ. Methods to score vertebral deformities in patients with rheumatoid arthritis. Br J Rheumatol 1997;36: 220-4.
23. Hochberg MC, Chang WR, Dwosh I, Lindsey S, Pincus T, Wolfe F. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 1992; 35:498-502.
24. Bijlsma JWJ, Oude Heuvel CHB, Zaalberg A. Development and validation of the Dutch questionnaire capacities of daily life (VDF) for patients with rheumatoid arthritis. J Rehabil Sci 1990;3:71-4.
25. Lems WF, Jahangier ZN, Jacobs JWG, Bijlsma JWJ. Vertebral fractures in patients with rheumatoid arthritis treated with corticosteroids. Clin Exp Rheumatol 1995;13:293-7.
26. Kleerekoper M, Parfitt AM, Ellis BI. Measurement of vertebral fracture rates in osteoporosis. In: Christiansen C, Arnaud CD, Nordin BEC, Parfitt AM, Peck WA, Riggs BL, eds. Proceedings of the Copenhagen International Symposium on Osteoporosis 1984. Copenhagen: Aalberg Stiftsbogtrykkeri, 1984:103-9.
27. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD. Rapid loss of vertebral mineral density after renal transplantation. N End J Med 1991; 325:544-50.
28. Cooper C, O'Neill T, Silman A. The epidemiology of vertebral fractures. Bone 1993;14:S89-97.
29. Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertbral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993;8:1137-48.
30. Wu CY, Li J, Jergas M, Genant HK. Comparison of semiquantitative and quantitative techniques for the assessment of prevalent and incident vertebral fractures. Osteoporosis Int 1995;5:354-70.
31. Walsh LJ, Wong CA, Pringle M, Tattersfield AE. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. Br Med J 1996;313:344-6.
32. Peat ID, Healy S, Reid DM, Ralston SH. Steroid induced osteoporosis: an opportunity for prevention. Ann Rheum Dis 1995;54:66-8.
33. American College of Rheumatology Task Force on Osteoporosis Guidelines. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 1996;39:1791-801.
34. Bijlsma JWJ. Prevention of glucocorticoid induced osteoporosis. Ann Rheum Dis 1997;56:507-9.
35. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1998;31:315-24.